IL-1β has been proven to play a mediating role in promoting local tissue destruction and distant organ complications, and IL-1β gene defects or injection of IL-1β antagonists can reduce the injury reactions of experimental AP patients [54]. This evidence concerns the gene IL1B and alkaline phosphatase measurement.